2014
DOI: 10.1016/j.jgar.2014.04.002
|View full text |Cite
|
Sign up to set email alerts
|

Vancomycin-resistant enterococci: Troublemaker of the 21st century

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
0
1

Year Published

2015
2015
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(12 citation statements)
references
References 95 publications
0
11
0
1
Order By: Relevance
“…Vancomycin is one of the last antibiotics which is highly effective against clinical infections caused by multidrug-resistant pathogens then resistance against vancomycin is critical among probiotics. 56,57 Ethical Issues No ethical issues were promulgated.…”
Section: Antibiotic Susceptibilitymentioning
confidence: 99%
“…Vancomycin is one of the last antibiotics which is highly effective against clinical infections caused by multidrug-resistant pathogens then resistance against vancomycin is critical among probiotics. 56,57 Ethical Issues No ethical issues were promulgated.…”
Section: Antibiotic Susceptibilitymentioning
confidence: 99%
“…Glycopeptide resistance in enterococci is mediated by van gene clusters, among which vanA and vanB are the most commonly reported worldwide. 1,2 VanA-type enterococci confer high-level resistance to both vancomycin and teicoplanin, whereas VanB-type enterococci display varying levels of vancomycin resistance but remain susceptible to teicoplanin. 3 In recent years, however, vanM has emerged as a new and prevalent resistance determinant in clinical enterococci in China, especially in the cities of Shanghai and Hangzhou.…”
Section: Introductionmentioning
confidence: 99%
“…Even A. baumannii, over the last 10 years, has emerged as one of the most problematic bacteria since it exhibits a wide spectrum of antimicrobial resistance mechanisms, such that treatment has been limited to a few antibiotics [22]. VRE likewise has emerged as one of the difficult-to-treat bacteria that cause several life-threatening infections, and for which a definitive and successful therapy remains elusive from the reach of an ever-growing number of patients [23] . The advent of these MDR bacteria has solicited some inquiries with regard to the future of therapeutic drugs in chemotherapy.…”
Section: Introductionmentioning
confidence: 99%